The RFRP-3 peptide of the present invention which is an agent for promoting prolactin
secretion is useful as a prophylactic and/or therapeutic agent for various diseases
associated with prolactin secretion, such as hypoovarianism, seminal vesicle hypoplasia,
menopausal syndrome and hypothyroidism.